Skip to Content

First Choice Healthcare Solutions, Inc. (FCHS)

Securities Class Action

Overview
  • Date:
  • 3/29/2019
  • Company Name:
  • First Choice Healthcare Solutions, Inc.
  • Stock Symbol:
  • FCHS
  • Class Period:
  • FROM 4/1/2014 TO 11/14/2018
  • Status:
  • Closed/Complete
  • Court:
  • U.S. District Court: Middle District of Florida

Case Finder

Locate any case using the tools below.

NEW YORK, March 29, 2019 – Bragar Eagel & Squire, P.C. announces that a class action lawsuit has been filed in the U.S. District Court for the Middle District of Florida on behalf of all persons or entities who purchased or otherwise acquired First Choice Healthcare Solutions, Inc. (Other OTC: FCHS) securities between April 1, 2014 and November 14, 2018 (the “Class Period”).  Investors have until May 28, 2019 to apply to the Court to be appointed as lead plaintiff in the lawsuit.

The complaint alleges that throughout the Class Period defendants were engaged in an undisclosed pump and dump scheme that manipulated and artificially inflated the price of First Choice common stock, and failed to disclose their involvement, rendering certain of their public statements materially misleading.  On November 15, 2018, after a federal criminal indictment and an SEC enforcement action were announced against Romandetti and his co-conspirators, First Choice common stock fell nearly 65%, closing at $0.35 per share.

If you purchased  First Choice securities during the Class Period or continue to hold shares purchased before the Class Period, have information, would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Melissa Fortunato by email at investigations@bespc.com, or telephone at (212) 355-4648, or by filling out the contact form below.  There is no cost or obligation to you.

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: